Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eurosilicone is a leading European manufacturer of silicone breast implants and tissue expanders for plastic and reconstructive surgery. Founded in 1988 and headquartered in Apt, France, the company provides a comprehensive range of aesthetic solutions, including the Matrix and Cristalix product lines. Eurosilicone operates as a core brand under the GC Aesthetics umbrella, following its merger with Nagor. The company's products are manufactured in ISO-certified facilities and are distributed to healthcare professionals and clinics in over 80 countries worldwide. Eurosilicone is recognized for its extensive clinical history and commitment to safety and quality in the medical aesthetics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eurosilicone.